Merck KGaA ADR
USUSDMerck KGaA ADR (XETRA:6MK) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 6. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
- Merck KGaA — MRK · XETRA DE Registreringsnummer ukendt
Om virksomheden
- Websted
- merck.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hovedkontor
- RAHWAY, Germany
- Administrerende direktør
- Dr. Kai Beckmann
- Ansatte
- 62 136
- Udestående aktier
- 646.21 mio. pr. 2026-07-31
- Free float
- 644.35 mio.
- Markedsværdi
- 67.93 mia. USD
- Insidere
- 0%
- Institutionelle investorer
- 0.02%
- Branche (SIC)
- Pharmaceutical Preparations
- ISIN
- US58933Y1055
- LEI
- 4YV9Y5M8S0BRK1RP0397
Beskrivelse
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Børser og tickere
| Børs | Ticker | Valuta | Pris | Type |
|---|---|---|---|---|
| US USA Stocks | MRK sekundær | USD | 141.94 +1.72% | almindelige aktier |
| LSE London Stock Exchange | 0QAH IOB | USD | 148.65 -0.12% | almindelige aktier |
| MI Borsa Italiana (Milan) | 1MRKX primær | EUR | 128.52 +2.11% | almindelige aktier |
| MX Mexican Stock Exchange | MRK sekundær | MXN | 2 561 +0.91% | almindelige aktier |
| VI Vienna Stock Exchange | MRK sekundær | EUR | 129.76 | almindelige aktier |
| XETRA Xetra | 6MK sekundær | EUR | 129.78 +0.09% | almindelige aktier |
Udbytte
Merck KGaA ADR (6MK) udbetaler udbytte kvartalsvis. I løbet af de sidste 12 måneder blev der betalt 3.0015 EUR pr. Aktie (betalinger: 4). Det svarer til cirka 2.31% af den nuværende aktiekurs. Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 15.12.2026.
| Ex-dato | Udbetaling | Beløb | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-09-15 | — | 0.7504 EUR | 0.6/2.3 % | kvartalsvis | XETRA:6MK |
| 2026-06-15 | — | 0.7504 EUR | 0.6/2.8 % | kvartalsvis | XETRA:6MK |
| 2026-03-16 | — | 0.7504 EUR | 0.6/2.8 % | kvartalsvis | XETRA:6MK |
| 2025-12-15 | — | 0.7504 EUR | 0.6/2.8 % | kvartalsvis | XETRA:6MK |
| 2025-09-15 | — | 0.7151 EUR | 0.6/2.7 % | kvartalsvis | XETRA:6MK |
| 2025-06-16 | — | 0.7151 EUR | 0.6/2.7 % | kvartalsvis | XETRA:6MK |
| 2025-03-17 | — | 0.7151 EUR | 0.6/2.1 % | kvartalsvis | XETRA:6MK |
| 2024-12-16 | — | 0.7151 EUR | 0.6/2.1 % | kvartalsvis | XETRA:6MK |
| 2024-09-16 | — | 0.6798 EUR | 0.5/2.1 % | kvartalsvis | XETRA:6MK |
| 2024-06-17 | — | 0.6798 EUR | 0.5/2.1 % | kvartalsvis | XETRA:6MK |
| 2024-03-14 | — | 0.6798 EUR | 0.5/2.0 % | kvartalsvis | XETRA:6MK |
| 2023-12-14 | — | 0.6798 EUR | 0.5/2.0 % | kvartalsvis | XETRA:6MK |
| 2023-09-14 | — | 0.6444 EUR | 0.5/2.0 % | kvartalsvis | XETRA:6MK |
| 2023-06-14 | — | 0.6444 EUR | 0.5/2.0 % | kvartalsvis | XETRA:6MK |
| 2023-03-14 | — | 0.6444 EUR | 0.5/1.9 % | kvartalsvis | XETRA:6MK |
| 2022-12-14 | — | 0.6444 EUR | 0.5/1.9 % | kvartalsvis | XETRA:6MK |
| 2022-09-14 | — | 0.6091 EUR | 0.5/1.9 % | kvartalsvis | XETRA:6MK |
| 2022-06-14 | — | 0.6091 EUR | 0.5/1.4 % | kvartalsvis | XETRA:6MK |
| 2022-03-14 | — | 0.6091 EUR | 0.5/0.9 % | kvartalsvis | XETRA:6MK |
| 2021-12-14 | — | 0.6091 EUR | 0.5/0.5 % | kvartalsvis | XETRA:6MK |
Nyheder denne uge
Endnu ingen nyheder fra virksomhedens websted.
Største ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| BlackRock | 9.2% | 227 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 161.32 mio. | 2026-06-30 |
| State Street Corporation | 4.88% | 120.41 mio. | 2026-06-30 |
| Wellington Management Gr… | 3.5% | 86.25 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 78.41 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.75% | 67.74 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 64 mio. | 2026-06-30 |
| Geode Capital Management… | 2.46% | 60.74 mio. | 2026-06-30 |
| Charles Schwab Investmen… | 2.2% | 54.37 mio. | 2026-06-30 |
| Morgan Stanley | 1.97% | 48.64 mio. | 2026-06-30 |
| FMR, LLC | 1.84% | 45.44 mio. | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.78% | 43.89 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 32.89 mio. | 2026-08-31 |
| Fidelity Concord Street… | 1.29% | 31.94 mio. | 2026-07-31 |
| SCHWAB STRATEGIC TRUST-S… | 1.25% | 30.86 mio. | 2026-05-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 30.22 mio. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 23.51 mio. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.75 mio. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.65% | 15.95 mio. | 2026-07-31 |
| VANGUARD SPECIALIZED FUN… | 0.57% | 13.97 mio. | 2026-07-31 |
| DAVIS ROBERT M (Chief Ex… | ≈0.02% | 450 351 | 2026-04-29 |
| CHATTOPADHYAY SANAT (Off… | ≈0.01% | 200 675 | 2026-04-29 |
| DELUCA RICHARD ROBERT JR… | ≈0% | 110 167 | 2026-08-12 |
| LI DEAN Y (Officer) | ≈0% | 94 431 | 2026-04-29 |
| LITCHFIELD CAROLINE (Chi… | ≈0% | 92 300 | 2026-04-29 |
| ZACHARY JENNIFER L (Gene… | ≈0% | 45 509 | 2026-08-12 |
| GUINDO CHIRFI (Officer) | ≈0% | 36 613 | 2026-08-13 |
| WILLIAMS DAVID MICHAEL (… | ≈0% | 31 716 | 2026-08-05 |
| ROMANELLI JOSEPH EDWARD… | ≈0% | 28 739 | 2026-01-26 |
| OOSTHUIZEN JOHANNES JACO… | ≈0% | 21 895 | 2026-04-29 |
| Trust for Professional M… | 0% | 24 803 | 2026-05-31 |
| Rhumbline Advisers | 0% | 10 919 | 2026-06-30 |
| SP Funds Trust-SP Funds… | 0% | 6 542 | 2026-07-31 |
| Atlas Capital Advisors I… | 0% | 2 467 | 2026-06-30 |
| Gamma Investing LLC | 0% | 2 302 | 2026-06-30 |
| Salomon & Ludwin, LLC | 0% | 356 | 2026-06-30 |
| PNC Financial Services G… | 0% | 2 | 2026-06-30 |
| The Vanguard Group | — | — | — |
